AIM ImmunoTech Inc.
ロング

Keeping a Close Watch on AIM

262
AIM is one of the stocks that have underwhelmed me in performance lately. However given current resistance wedges, I think as an entry point right now it would seem low to mid risk. I believe going in as a long hold, you can expect some positive retracement, and quite possibly a $3.15 price target by end of August. That being said, pursue at your own risk. As always, everything I say is on the basis of opinion.

免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。